Status:
COMPLETED
Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Recurrent Urinary Tract Infections
Eligibility:
FEMALE
18-50 years
Brief Summary
Due to genetic polymorphism about 15%-30% of the world population have low levels of MBL (Mannose Binding Lectin) in serum (below 500ng/mL). Different studies reported correlation between polymorphism...
Eligibility Criteria
Inclusion
- women above 18 years old.
- premenopausal
- recurrent UTI
Exclusion
- pregnancy
- immunocompromised
- active malignancy
- HIV carrier
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00678028
Start Date
February 1 2008
Last Update
April 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ha'Emek Medical Center
Afula, Israel, 18101